Survival improvement for patients with metastatic colorectal cancer over twenty yearsFadl A. Zeineddine, John Paul Shen, Ryan Huey et al.|npj Precision Oncology|2023Cited by 172
Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, <i>BRAF</i><sup>V600E</sup> metastatic colorectal cancer.Van K. Morris, Scott Kopetz, Christine M. Parseghian et al.|Journal of Clinical Oncology|2022Cited by 78
Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer ModelsMaria Pia Morelli, Sabine Eckhardt|Clinical Cancer Research|2011Cited by 49